Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...

For youth and adolescents battling cancer, researchers at the University of Calgary are finding ways to ensure they may still be able to have biological children later in life. In some cases where ...

NovoCure (Nasdaq: NVCR) announced good results today in its trial of a treatment for pancreatic cancer. The announcement ...

Citadel ended September with 91% fewer Palantir shares, despite the stock's eye-popping gains, after selling about 5.2 ...